An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
about
Heterogeneity and the genetics of autism.Characterization of BRCA1 and BRCA2 mutations in a large United States samplePenetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumDifferential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing.Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.Forth nightly review: hereditary ovarian carcinoma.German family study on hereditary breast-ovarian cancerAttitudes towards cancer predictive testing and transmission of information to the familyMutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sitesUsing gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genesA population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.A large multisite cancer family is linked to BRCA2.Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative.Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear fociScreening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancerThe contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancerAssociations between gene expression variations and ovarian cancer risk alleles identified from genome wide association studiesBRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers.Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer.Screening for 185delAG in the AshkenazimBRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer GroupMutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?Interactions between genetic and reproductive factors in breast cancer risk in a French family sample.A highly accurate, low cost test for BRCA1 mutations.Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer.Genetic heterogeneity in hereditary breast cancer: role of BRCA1 and BRCA2.A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
P2860
Q24535727-0A0C6916-806D-46E6-9463-75C4C5E39A0FQ28383993-BBF1BF1A-495C-4792-BD9E-C6D5A413937DQ28387387-DA8AECBE-D55E-46F8-BB02-8DE00FB43970Q29619206-B6A2A723-9BE7-4844-8B2D-27BE225767B6Q31056438-FDFE5515-FCC1-41FF-A2FD-2D00CC106729Q33214483-9E44C2F2-1DFA-4B59-9B68-8814DB99C227Q33470293-FC66C01C-4116-40C8-AD53-D7B1C2248BE0Q33542652-7F221BEF-0379-44CD-ABCB-851C20802D44Q33677619-94BBF5A7-98A3-4B89-8A18-D882A43C706EQ33677753-91DDDAA4-3BCF-473A-AFE3-9E518F8E55D7Q33677871-A4128F2B-6DF6-448E-BBB3-7B8495D9A3D2Q33680173-F2383C27-FE72-41EE-A2A1-B9F9F6199901Q33680801-E8E2A4DD-E8FF-4AAE-900D-23DBB28F562AQ33683002-8CC46254-5E52-4341-8E2A-570AE153E65FQ33905879-2573BECC-AE37-415E-AF25-1E32CDED4E11Q33968470-DB1F0C2E-2699-4DC9-A8B4-D84E631D66B8Q34144140-BA636E60-D003-4E72-8186-B0EBD4184345Q34145544-0BE5F029-BA6F-40E7-9024-A0E63B1789A6Q34145680-AF53FB09-6270-4BAC-835C-A4058FEABE66Q34146408-DC7B035B-F846-469C-B6E5-EF6D537457F5Q34387715-6E974EC1-A6ED-41BE-A1A2-AA0735EDEEE4Q34417238-4E65CFBD-C44B-4B44-9704-B093E819D4CDQ34469596-42092192-D914-46D6-A69A-0F31EE3BED0CQ34480647-95C7B6BF-6A37-4F40-9CF1-ACE44D1850B8Q34584767-9628E2CF-F07A-4A4A-B30A-EDA6D28D4EECQ34977063-C65AEF25-EF85-4958-A6AC-7E6A43FA7155Q35006892-9CA87B91-5F21-4134-94B5-B24A0D780B36Q35012736-BD3EFE49-32C4-4675-BF9A-09E976349A9DQ35167715-B17F32A0-9E62-4EF7-A480-0BDC1B689BA2Q35238470-B5BDB57D-1CF3-414E-83CB-20BBB9253BE8Q35238484-8F28BD6E-EA7F-43BF-8602-7096E0F60265Q35238904-6C8A7C9D-F75F-427F-8BBE-C9A0D825545CQ35249388-D7D8B2BA-604A-4173-8B94-804AAB1F79A8Q35430890-58630153-AC74-40B3-BB69-C980E76445F4Q35643852-D51F8C4B-894C-4025-A8EB-4B88950C50A5Q35644167-BD3C1F3D-4691-4FB5-ADFF-211C22093D64Q35787027-71BD7F47-7768-429F-9092-52AD7D67631EQ35795392-575E7000-C22A-4EA6-8FA6-877B4CFC75FEQ35882332-5281A249-5ED9-4684-A79B-99943F7B863EQ35882413-5B39CA84-731B-425B-AF34-956D1D8D0527
P2860
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@ast
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@en
type
label
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@ast
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@en
prefLabel
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@ast
An evaluation of genetic heter ...... ast Cancer Linkage Consortium.
@en
P2093
P2860
P1476
An evaluation of genetic heter ...... east Cancer Linkage Consortium
@en
P2093
Barkardottir RB
P2860
P304
P407
P577
1995-01-01T00:00:00Z